Skip to main content

Endocrine Dysfunction in Children with Cerebral Palsy

  • Living reference work entry
  • First Online:
Cerebral Palsy

Abstract

With a few exceptions, children and adults with cerebral palsy are not at greater risk for endocrine disorders than the general population. However, endocrine disorders may be a factor in the cause of cerebral palsy and may be misdiagnosed as cerebral palsy. The diagnosis of endocrine disorders can be a challenge in the setting of cerebral palsy, and special consideration must be made by those who provide care to these patients. This chapter discusses the most common endocrine disorders of the pituitary, thyroid, and adrenal glands, including congenital and acquired conditions. General guidelines for screening and treatment in patients with cerebral palsy are presented.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Andersen UM, Lund HT (1995) Hypoglycemia caused by growth hormone deficiency. Two cases in children with cerebral paresis. Ugeskr Laeger 157(12):1681–1682

    CAS  PubMed  Google Scholar 

  • Brent GA, Weetman AP (2016) Hypothyroidism and thyroiditis. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds) Williams textbook of endocrinology. Elsevier, Philadelphia, pp 416–448

    Google Scholar 

  • Devesa J, Casteleiro N, Rodicio C, Lopez N, Reimunde P (2010) Growth hormone deficiency and cerebral palsy. Ther Clin Risk Manag 6:413–418

    Article  CAS  Google Scholar 

  • Hamza RT, Ismail MA, Hamed AI (2011) Growth hormone deficiency in children and adolescents with cerebral palsy: relation to gross motor function and degree of spasticity. Pak J Biol Sci 14(7):433–440

    Article  CAS  Google Scholar 

  • Han Ze D, Kang L, Hui P, Gong-Wei D (2011) Clinical analysis of misdiagnosis in 70 children with primary hypothyroidism. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 33(1):14–17

    PubMed  Google Scholar 

  • Hong T, Paneth N (2008) Maternal and infant thyroid disorders and cerebral palsy. Semin Perinatol 32(6): 438–445

    Article  Google Scholar 

  • Kaiser U, Ho KKY (2016) Pituitary physiology and diagnostic evaluation. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds) Williams textbook of endocrinology. Elsevier, Philadelphia, pp 176–231

    Google Scholar 

  • Kuperminc MN, Gurka MJ, Houlihan CM, Henderson RC, Roemmich JN, Rogol AD, Stevenson RD (2009) Puberty, statural growth, and growth hormone release in children with cerebral palsy. J Pediatr Rehabil Med 2(2):131–141

    PubMed  PubMed Central  Google Scholar 

  • Osborn DA, Hunt RW (2007) Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 1:CD005948

    Google Scholar 

  • Stewart PM, Newell-Price JDC (2016) The adrenal cortex. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds) Williams textbook of endocrinology. Elsevier, Philadelphia, pp 490–555

    Google Scholar 

  • Suzumura H, Nitta A, Tsuboi Y, Watabe Y, Kuribayashi R, Arisaka O (2011) Thyroxine for transient hypothyroxinemia and cerebral palsy in extremely preterm infants. Pediatr Int 53(4):463–467

    Article  CAS  Google Scholar 

  • Trabacca A, De Rinaldis M, Gennaro L, Losito L (2012) Septo-optic dysplasia-plus and dyskinetic cerebral palsy in a child. Neurol Sci 33(1):159–163

    Article  Google Scholar 

  • Trinh A, Wong P, Fahey MC, Brown J, Churchyard A, Strauss BJ, Ebeling PR, Fuller PJ, Milat F (2016) Musculoskeletal and endocrine health in adults with cerebral palsy: new opportunities for intervention. J Clin Endocrinol Metab 101(3):1190–1197

    Article  CAS  Google Scholar 

  • Uchiyama A, Kushima R, Watanabe T, Kusuda S (2015) Effect of l-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial. J Pediatr Endocrinol Metab 28(1–2):177–182

    CAS  PubMed  Google Scholar 

  • Uday S, Shaw N, Krone R, Kirk J (2017) Hypopituitarism in children with cerebral palsy. Arch Dis Child 102(6):559–561

    Article  Google Scholar 

  • Watterberg KL, Shaffer ML, Mishefske MJ, Leach CL, Mammel MC, Couser RJ, Abbasi S, Cole CH, Aucott SW, Thilo EH, Rozycki HJ, Lacy CB (2007) Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants. Pediatrics 120(1):40–48

    Article  Google Scholar 

  • Worley G, Houlihan CM, Herman-Giddens ME, O’Donnell ME, Conaway M, Stallings VA, Chumlea WC, Henderson RC, Fung EB, Rosenbaum PL, Samson-Fang L, Liptak GS, Calvert RE, Stevenson RD (2002) Secondary sexual characteristics in children with cerebral palsy and moderate to severe motor impairment: a cross-sectional survey. Pediatrics 110(5):897–902

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert C. Olney .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Elmufti, H., Olney, R.C. (2018). Endocrine Dysfunction in Children with Cerebral Palsy. In: Miller, F., Bachrach, S., Lennon, N., O'Neil, M. (eds) Cerebral Palsy. Springer, Cham. https://doi.org/10.1007/978-3-319-50592-3_222-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-50592-3_222-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-50592-3

  • Online ISBN: 978-3-319-50592-3

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics